The poloxamer P85 is protective against Listeria monocytogenes invasion

Foodborne Pathogens and Disease

Volumn 5, Issue 6, 2008, Pages 859-865

  Neudeck, Brien L ^a,c   Alford, Terri D ^a   Faith, Nancy G ^b   Czuprynski, Charles J ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEOXYGLUCOSE; GENTAMICIN; POLOXAMER; POLOXAMER P85; SODIUM AZIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL STRAIN CACO 2; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; FOOD CONTAMINATION; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ADENOSINE TRIPHOSPHATE; ANIMALS; BACTERIAL ADHESION; BIOLOGICAL ASSAY; CACO-2 CELLS; DISEASE MODELS, ANIMAL; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MALE; MICE; ORGAN SPECIFICITY; POLOXAMER; RANDOM ALLOCATION; SPLEEN;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; MURINAE; MUS;

EID: 57749115829     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2008.0125     Document Type: Article

References (28)

1. Allison AC and Byars NE. Adjuvant formulations and their mode of action. Semin Immunol 1990;2:369-374.
2. Alvarez-Dominguez C, Roberts R, and Stahl PD. Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. J Cell Sci 1997;110:731-743.
3. Astafieva I, Maksimova I, Lukanidin E, et al. Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer. FEBS Lett 1996;389:278-280.
4. BASF. Pluronic® P85 surfactant. Product information. Florham Park, NJ: BASF. 2002.
5. Batrakova EV, Li S, Elmquist WF, et al. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br J Cancer 2001a;85:1987-1997.
6. Batrakova EV, Li S, Vinogradov SV, et al. Mechanism of pluronic effect on P-glycoprotein efflux system in bloodbrain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 2001b;299:483-493.
7. Batrakova EV, Miller DW, Li S, et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J Pharmacol Exp Ther 2001c;296:551-557.
8. Farber JM, Ross WH, and Harwig J. Health risk assessment of Listeria monocytogenes in Canada. Int J Food Microbiol 1996;30:145-156.
9. Gaillard JL, Berche P, Mounier J, et al. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun 1987;55:2822-2829.
10. Geyer RP. Perfluorochemicals as oxygen transport vehicles. Journal of Biomaterials, Artificial Cells and Artificial Organs 1988;16:31-49.
11. Gupta E, Luo F, Lallo A, et al. The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s). Anticancer Res 2000;20:1013-1016.
12. Haak-Frendscho M, Brown JF, Iizawa Y, et al. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 1992a;148:3978-3985.
13. Haak-Frendscho M and Czuprynski CJ. Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection. Infect Immun 1992b;60:1406-1414.
14. Haak-Frendscho M, Kurtz RS, and Czuprynski CJ. rIL-1 alpha enhances adoptive transfer of resistance to Listeria monocytogenes infection. Microb Pathog 1991;10:385-392.
15. Hurd S, Phan Q, Hadler J, et al. Multistate outbreak of listeriosis - United States. MMWR, 2000.
16. Ireton K, Payrastre B, Chap H, et al. A role for phosphoinositide 3-kinase in bacterial invasion. Science 1996;274:780-782.
17. Kabanov AV, Batrakova EV, and Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189-212.
18. Kabanov AV, Batrakova EV, Sriadibhatla S, et al. Polymer genomics: shifting the gene and drug delivery paradigms. J Control Release 2005;101:259-271.
19. Kirillova GP, Mokhova EN, Dedukhova VI, et al. The influence of pluronics and their conjugates with proteins on the rate of oxygen consumption by liver mitochondria and thymus lymphocytes. Biotechnol Appl Biochem 1993;18:329-339.
20. March KL, Madison JE, and Trapnell BC. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum Gene Ther 1995;6:41-53.
21. Moghimi SM and Rajabi-Siahboomi AR. Recent advances in cellular, sub-cellular and molecular targeting. Adv Drug Deliv Rev 2000;41:129-133.
22. Nagarajan R. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPO-PEO) block copolymers. Colloids Surf B Biointerfaces 1999;18:55-72.
23. Notermans S, Dufrenne J, Teunis P, et al. Studies on the risk assessment of Listeria monocytogenes. J Food Prot 1998;61:244-248.
24. Riera M, Chillon M, Aran JM, et al. Intramuscular SP1017-formulated DNA electrotransfer enhances transgene expression and distributes hHGF to different rat tissues. J Gene Med 2004;6:111-118.
25. Roll JT, Young KM, Kurtz RS, et al. Human rTNF alpha augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1 alpha. Immunology 1990;69:316-322.
26. Schlech WF III, Lavigne PM, Bortolussi RA, et al. Epidemic listeriosis-evidence for transmission by food. N Engl J Med 1983;308:203- 206.
27. Schmolka IR. Poloxamers in the pharmaceutical industry. In: Polymers for Controlled Drug Delivery. Tarcha PJ (ed). Boca Raton, FL: CRC Press, 1990, pp. 189-214.
28. Wagner RD, Steinberg H, Brown JF, et al. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb Pathog 1994;17:175-186.